Literature DB >> 20443239

Bridging the gap between experimental and non-experimental neuroepidemiology, and ultimately - between neuroepidemiological research and practice: round table discussion at the First International Congress on Clinical Neurology and Epidemiology.

Valery Feigin1, John F Kurtzke, Amos Korczyn, Ettore Beghi, Allen Brown.   

Abstract

A highlight of the congress was an interactive and inclusive discussion of the existing gaps between clinical neurology and epidemiology and the ways of bridging these gaps. Some perceptions, challenges and scientific issues between experimental and non-experimental neuroepidemiology were brought to light. Recognizing that all study designs have advantages and disadvantages, panelists stressed that studies should aim to complement each other while answering important research- or practice-related questions. Advocated strategies included introducing more epidemiology into the medical school or residency curriculum, developing consistency in the reporting of epidemiological data to improving the strength and utility of the evidence, as well as nurturing collaborations that recognize the usefulness of both experimental and non-experimental epidemiological studies. These strategies will in the end benefit clinical practice. Indeed, clinical knowledge improves with experience and critical scientific evidence that can change perceptions, yet, individualized disease management will probably always remain an art rather than an exact science. Nevertheless, strong epidemiological studies and collaborations can influence government and public health policies. Bridging the gap between neuroepidemiological research and practice - whether through improved communication, education or basic science- is clearly a pressing challenge that requires our concerted and sustained effort.

Mesh:

Year:  2009        PMID: 20443239     DOI: 10.1159/000252942

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  5 in total

1.  Trending autoregulatory indices during treatment for traumatic brain injury.

Authors:  Nam Kim; Alex Krasner; Colin Kosinski; Michael Wininger; Maria Qadri; Zachary Kappus; Shabbar Danish; William Craelius
Journal:  J Clin Monit Comput       Date:  2015-10-07       Impact factor: 2.502

Review 2.  From Data to Action: Neuroepidemiology Informs Implementation Research for Global Stroke Prevention and Treatment.

Authors:  George A Mensah; Ralph L Sacco; Barbara G Vickrey; Uchechukwu K A Sampson; Salina Waddy; Bruce Ovbiagele; Jeyaraj Durai Pandian; Bo Norrving; Valery L Feigin
Journal:  Neuroepidemiology       Date:  2015-10-28       Impact factor: 3.282

3.  High resolution spectral domain optical coherence tomography (SD-OCT) in multiple sclerosis: the first follow up study over two years.

Authors:  Nermin Serbecic; Fahmy Aboul-Enein; Sven C Beutelspacher; Clemens Vass; Wolfgang Kristoferitsch; Hans Lassmann; Andreas Reitner; Ursula Schmidt-Erfurth
Journal:  PLoS One       Date:  2011-05-17       Impact factor: 3.240

4.  Development of the standards of reporting of neurological disorders (STROND) checklist: a guideline for the reporting of incidence and prevalence studies in neuroepidemiology.

Authors:  Derrick A Bennett; Carol Brayne; Valery L Feigin; Suzanne Barker-Collo; Michael Brainin; Daniel Davis; Valentina Gallo; Nathalie Jetté; André Karch; John F Kurtzke; Pablo M Lavados; Giancarlo Logroscino; Gabriele Nagel; Pierre-Marie Preux; Peter M Rothwell; Lawrence W Svenson
Journal:  Eur J Epidemiol       Date:  2015-06-19       Impact factor: 8.082

5.  Neuromyelitis optica in Austria in 2011: to bridge the gap between neuroepidemiological research and practice in a study population of 8.4 million people.

Authors:  Fahmy Aboul-Enein; Thomas Seifert-Held; Simone Mader; Bettina Kuenz; Andreas Lutterotti; Helmut Rauschka; Paulus Rommer; Fritz Leutmezer; Karl Vass; Agathe Flamm-Horak; Robert Stepansky; Wilfried Lang; Elisabeth Fertl; Thomas Schlager; Thomas Heller; Christian Eggers; Georg Safoschnik; Siegrid Fuchs; Jörg Kraus; Hamid Assar; Stefan Guggenberger; Martin Reisz; Peter Schnabl; Martina Komposch; Philipp Simschitz; Alena Skrobal; Alexander Moser; Mario Jeschow; Dorothea Stadlbauer; Manfred Freimüller; Michael Guger; Susanne Schmidegg; Claudia Franta; Vera Weiser; Stefan Koppi; Margret Niederkorn-Duft; Bettina Raber; Iris Schmeissner; Julia Jecel; Alexander Tinchon; Maria K Storch; Markus Reindl; Thomas Berger; Wolfgang Kristoferitsch
Journal:  PLoS One       Date:  2013-11-05       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.